Approval of Cologuard Plus follows results from the BLUE-C study, which demonstrated a 95% sensitivity for detecting colorectal cancer. The FDA has approved Exact Sciences' Cologuard Plus, a ...

A blood test to screen for colorectal cancer is one step closer to receiving approval from the U.S. Food and Drug Administration. An FDA advisory panel -- the Medical Devices Advisory Committee -- ...

A new type of blood test can detect colon cancer with nearly a 90 percent accuracy rate, a potential breakthrough in the epidemic. A new study from researchers at New York University found the ...

The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older. The maker of the test, Palo Alto, California-based ...

The device can detect potential warning signs of serious conditions. Reese Pharmaceutical is launching a new at home colon cancer screening test as part of its diagnostic portfolio. The ...

MADISON, Wis. - A new modeling study published Tuesday in the Journal of the National Cancer Institute indicates that Cologuard Plus, a triennial next-generation multitarget stool DNA test, is the ...

(NEXSTAR) — An unexpected delivery at your door may not always be an unwelcome surprise — just ask one Kentucky boy about the thousands of dollars worth of lollipops that arrived at his home earlier ...

Blood tests for colorectal cancer are an option for patients who would otherwise not be screened, but they are not as effective as colonoscopies or stool tests, a Stanford Medicine-led study found.

The Food and Drug Administration has approved a blood test that could effectively screen for colon cancer. The FDA approved Shield, the premier blood test of Guardant Health. According to NBC News, ...

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, is teaming up with actor and horror icon Matthew Lillard to encourage people 45 and older to get ...